Name: New Therapies for Acute Myeloid Leukaemia (en Inglés)
Price: 82584.00 COP
Availability: InStock
Author: Paul Faduola
ISBN: 9781492991014

portada New Therapies for Acute Myeloid Leukaemia (en Inglés)

New Therapies for Acute Myeloid Leukaemia (en Inglés)

Formato

Libro Físico

Editorial

Createspace

Autor

Paul Faduola

Idioma

Inglés

N° páginas

118

Encuadernación

Tapa Blanda

ISBN13

9781492991014

New Therapies for Acute Myeloid Leukaemia (en Inglés)

Paul Faduola (Autor) · Createspace · Tapa Blanda

Libro Nuevo Importado

Envío: 18 a 24 días háb.

$ 165.167$ 82.584

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 82.584

Llega entre el 31 Ago y el 09 Sep a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "New Therapies for Acute Myeloid Leukaemia (en Inglés)"

Stem cell transfusion have undeniable benefits for patients with Acute Myeloid Leukemia (AML) especially for augmenting the mostly suppressed normal precursor stem cell necessary for fighting infections. While many patients use own stem cells, other patients that might benefit from this treatment are unable to use own stem cells and may lack Human Leucocyte Antigen (HLA) identical donor because of HLA polymorphism. Stem cells collected from the bone marrow, umbilical cord blood and peripheral blood stem cells may be from own or HLA partially mismatched unrelated or related donors. The data obtained show that hematologic recovery is highest in peripheral blood and lower in cord blood than in bone marrow, graft versus host disease is higher in peripheral blood than in bone marrow and lowest in cord blood, incidence of relapse and survival were comparable across sources, mortality is higher in cord blood than in peripheral blood and bone marrow and is mostly as a result of infection due to poor engraftment .This comparison is aimed at improving the quality of decision taking on source of stem cells for transfusion in cases of AML as it compares cord blood, peripheral blood and bone marrow in a single study .